Open AccessExpression of a human cytomegalovirus gp58 antigenic domain fused to the hepatitis B virus nucleocapsid protein
Author(s) -
Tarar Maryam R.,
Emery Vincent C.,
Harrison Tim J.
Publication year - 1996
Publication title -
fems immunology & medical microbiology
Language(s) - English
Resource type - Journals
eISSN - 1574-695X
pISSN - 0928-8244
DOI - 10.1111/j.1574-695x.1996.tb00135.x
Subject(s) - hbcag , antigenicity , epitope , virology , biology , human cytomegalovirus , polyclonal antibodies , antigen , immunogenicity , immunogen , antibody , monoclonal antibody , microbiology and biotechnology , hepatitis b virus , virus , hbsag , immunology
Hepatitis B virus core antigen (HBcAg) has been used as a carrier for expression and presentation of a variety of heterologous viral epitopes in particulate form. The aim of this study was to produce hybrid antigens comprising HBcAg and an immunogenic epitope of human cytomegalovirus (HCMV). A direct comparison was made of amino and carboxyl terminal fusions in order to investigate the influence of position of the foreign epitope on hybrid core particle formation, antigenicity and immunogenicity. HCMV DNA encoding a neutralising epitope of the surface glycoprotein gp58 was either inserted at the amino terminus or fused to the truncated carboxyl terminus of HBcAg and expressed in Escherichia coli . The carboxyl terminal fusion (HBc 3–144 ‐HCMV) was expressed at high levels and assembled into core like particles resembling native HBcAg. Protein with a similar fusion at the amino terminus (HCMV‐HBc 1–183 ) could not be purified or characterised immunologically, although it formed core like particles. HBc 3–144 ‐HCMV displayed HBc antigenicity but HCMV antigenicity could not be detected by radioimmunoassay or western blotting using anti‐HCMV monoclonal antibody 7–17 or an anti‐HCMV human polyclonal antiserum. Following immunisation of rabbits with HBc 3–144 ‐HCMV, a high titre of anti‐HBc specific antibody was produced along with lower titres of HCMV/gp58 specific antibody.